These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34465866)

  • 1. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
    Perner F; Schnoeder TM; Xiong Y; Jayavelu AK; Mashamba N; Santamaria NT; Huber N; Todorova K; Hatton C; Perner B; Eifert T; Murphy C; Hartmann M; Hoell JI; Schröder N; Brandt S; Hochhaus A; Mertens PR; Mann M; Armstrong SA; Mandinova A; Heidel FH
    Leukemia; 2022 Feb; 36(2):426-437. PubMed ID: 34465866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
    Jayavelu AK; Schnöder TM; Perner F; Herzog C; Meiler A; Krishnamoorthy G; Huber N; Mohr J; Edelmann-Stephan B; Austin R; Brandt S; Palandri F; Schröder N; Isermann B; Edlich F; Sinha AU; Ungelenk M; Hübner CA; Zeiser R; Rahmig S; Waskow C; Coldham I; Ernst T; Hochhaus A; Jilg S; Jost PJ; Mullally A; Bullinger L; Mertens PR; Lane SW; Mann M; Heidel FH
    Nature; 2020 Dec; 588(7836):157-163. PubMed ID: 33239784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.
    Zhou H; Liu W; Zhou Y; Hong Z; Ni J; Zhang X; Li Z; Li M; He W; Zhang D; Chen X; Zhu J
    J Exp Clin Cancer Res; 2021 Nov; 40(1):353. PubMed ID: 34753494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAN and YBX1 are required for cell proliferation and IL-4 expression and linked to poor prognosis in oral squamous cell carcinoma.
    Che X; Liu M; Li D; Li Z; Guo J; Jia R
    Exp Cell Res; 2021 Sep; 406(2):112767. PubMed ID: 34364882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.
    Li H; Zhang D; Fu Q; Wang S; Wang Z; Zhang X; Chen X; Zhu X; An N; Chen Y; Zhou L; Lu D; Zhao N
    Blood Adv; 2023 Sep; 7(17):4874-4885. PubMed ID: 37339496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
    Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.
    Liu S; Marneth AE; Alexe G; Walker SR; Gandler HI; Ye DQ; Labella K; Mathur R; Toniolo PA; Tillgren M; Gokhale PC; Barbie D; Mullally A; Stegmaier K; Frank DA
    Blood Adv; 2018 Dec; 2(23):3428-3442. PubMed ID: 30504235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3.
    Jing Y; Jiang X; Lei L; Peng M; Ren J; Xiao Q; Tao Y; Tao Y; Huang J; Wang L; Tang Y; Yang Z; Yang Z; Zhang L
    J Exp Clin Cancer Res; 2021 Oct; 40(1):312. PubMed ID: 34615546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival.
    Bommert KS; Effenberger M; Leich E; Küspert M; Murphy D; Langer C; Moll R; Janz S; Mottok A; Weissbach S; Rosenwald A; Bargou R; Bommert K
    Leukemia; 2013 Feb; 27(2):441-50. PubMed ID: 22772059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.
    Ohanian M; Bueso-Ramos C; Ok CY; Lin P; Patel K; Alattar ML; Khoury JD; Rozovski U; Estrov Z; Huh YO; Cortes J; Abruzzo LV
    Cancer Genet; 2015 Nov; 208(11):571-4. PubMed ID: 26382622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
    Hartley AV; Wang B; Mundade R; Jiang G; Sun M; Wei H; Sun S; Liu Y; Lu T
    Sci Rep; 2020 Sep; 10(1):15934. PubMed ID: 32985589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.
    Long J; Jia MY; Fang WY; Chen XJ; Mu LL; Wang ZY; Shen Y; Xiang RF; Wang LN; Wang L; Jiang CH; Jiang JL; Zhang WJ; Sun YD; Chang L; Gao WH; Wang Y; Li JM; Hong DL; Liang AB; Hu J
    Blood; 2020 Apr; 135(17):1472-1483. PubMed ID: 32315388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic Significance of YBX1 Expression in Acute Myeloid Leukemia Relapse.
    Gouda MBY; Hassan NM; Kandil EI; Haroun RA
    Curr Res Transl Med; 2022 Jul; 70(3):103336. PubMed ID: 35278854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
    Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
    Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
    Heydt Q; Larrue C; Saland E; Bertoli S; Sarry JE; Besson A; Manenti S; Joffre C; Mansat-De Mas V
    Oncogene; 2018 Feb; 37(6):787-797. PubMed ID: 29059168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
    Li J; Wang M; Chen X
    Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.